359 results on '"Jiménez-Fonseca P"'
Search Results
2. Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
3. Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer
4. CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer
5. Using the emotional functioning in clinical practice to detect psychological distress in patients with advanced thoracic and colorectal cancer
6. Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials
7. Psychometric properties of the Spanish version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
8. Is short-course radiotherapy and total neoadjuvant therapy the new standard of care in locally advanced rectal cancer? A sensitivity analysis of the RAPIDO clinical trial
9. Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
10. Anxiety and depression in patients with advanced cancer during the COVID-19 pandemic
11. Dignity and psychosocial related variables in elderly advanced cancer patients
12. Psychological distress and resilience in patients with advanced cancer during the Covid-19 pandemic: the mediating role of spirituality
13. The popularity of neurology in Spain: an analysis of specialty selection
14. Popularidad de Neurología en España: análisis de la elección de la especialidad
15. Unilateral exophthalmos secondary to esophageal adenocarcinoma metastasis to the medial rectus muscle
16. Influencia de la dignidad percibida y estrategias de afrontamiento en la incertidumbre y malestar emocional de pacientes con cáncer avanzado.
17. Intensive care in cancer patients in the age of immunotherapy and molecular therapies: Commitment of the SEOM-SEMICYUC
18. SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019)
19. Psychometric properties and factorial analysis of invariance of the Satisfaction with Life Scale (SWLS) in cancer patients
20. Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors
21. Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors
22. Nutritional support and parenteral nutrition in cancer patients: an expert consensus report
23. Valor pronóstico de la tomografía computarizada en la tromboembolia pulmonar aguda
24. On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism
25. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU
26. Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry
27. Optimizing Somatostatin Analog Use in Well or Moderately Differentiated Gastroenteropancreatic Neuroendocrine Tumors
28. The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score
29. The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism
30. Supportive care in pancreatic ductal adenocarcinoma
31. Key points to optimizing management and research on cancer-associated thrombosis
32. Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer
33. Consensus on the management of advanced radioactive iodine-refractory differentiated thyroid cancer on behalf of the Spanish Society of Endocrinology Thyroid Cancer Working Group (GTSEEN) and Spanish Rare Cancer Working Group (GETHI)
34. Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors
35. Estudio psicométrico de las pruebas MIR de 2020 y 2021
36. PCR65 Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality of Life (HRQoL) Outcomes in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC): The Rationale-306 Study
37. Chronic opioid therapy in long-term cancer survivors
38. CT scan prior to radiotherapy in unresectable, locally advanced, non-small cell carcinoma of the lung: is it always necessary?
39. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma
40. Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study
41. Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)
42. Management of infection and febrile neutropenia in patients with solid cancer
43. 1940TiP Sacituzumab govitecan in patients with advanced or metastatic radioactive-iodine refractory thyroid carcinoma and anaplastic thyroid carcinoma: The phase II SETHY, GETNE-T2318 trial design
44. 1935P Sequence matters: Impact of first-line response in overall therapeutic outcome in differentiated thyroid cancer. Data from the Spanish national registry of thyroid cancer (REGETNE-Tiroides)
45. 1936P Treatment outcomes of patients with anaplastic thyroid carcinoma (atc): Multicentric data from spanish national registry (regetne-tiroides)
46. 1856P Prediction of clinically significant bleeding in anticoagulated patients for cancer-associated venous thromboembolism: Validation of B-CAT score in a cohort from the TESEO study
47. 1157P Retreatment with peptide receptor radionuclide therapy (PRRT) in patients (p) with neuroendocrine tumors (NET): Spanish clinical experience from SEPTRALU national registry
48. 1144O Osteopontin (OPN) predicts the efficacy of anti-angiogenic therapy with multikinase inhibitors (MKIs) in advanced neuroendocrine tumors (NETs): Underlying molecular mechanisms
49. 1143O Refining molecular classification of neuroendocrine tumors from diverse origins using multi-omic integration models: Unveiling novel neuroendocrine subtypes and their clinical implications
50. 1142O Multivariable analysis of streptozotocin plus 5-fluorouracil and everolimus sequences in advanced pancreatic neuroendocrine tumor patients: The SEQTOR trial (GETNE-1206)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.